He aha ʻo Adalimumab-fkjp: Nā hoʻohana, ka nui o ka lāʻau, nā hopena ʻaoʻao a me nā mea hou aku

He lāʻau lapaʻau biosimilar ʻo Adalimumab-fkjp e kōkua ana i ka mālama ʻana i nā maʻi autoimmune e like me ka rheumatoid arthritis, psoriasis, a me ka maʻi ʻōpū mumū. Hana kēia lāʻau lapaʻau injectable ma ka pale ʻana i kahi protein i loko o kāu ʻōnaehana pale e hoʻoulu ai i ka mumū a me ka pōʻino hui. E noʻonoʻo iā ia he lāʻau lapaʻau i manaʻo ʻia e kōkua i ka hoʻomaha ʻana i kāu pane immune overactive, e ʻae ana i kou kino e hoʻōla a maikaʻi.

He aha ʻo Adalimumab-fkjp?

He mana biosimilar ʻo Adalimumab-fkjp o ka lāʻau adalimumab kumu, ʻo ia hoʻi, hana like ia me ka lāʻau kuhikuhi akā ʻoi aku ka liʻiliʻi o ke kumukūʻai. No ka papa o nā lāʻau lapaʻau i kapa ʻia ʻo TNF blockers a i ʻole biologics. Hiki i kāu kauka ke kuhikuhi i kēia i ka wā e hoʻouka hewa ai kāu ʻōnaehana pale i nā ʻāpana olakino o kou kino, e hoʻoulu ana i ka ʻeha a me ka mumū.

Kōkua ka ʻāpana

He hana ka maʻi i ka mumū e hiki ke hana i ka ʻeha nui a pili i kou ola i kēlā me kēia lā. Kōkua ka lāʻau lapaʻau i ka hoʻēmi ʻana i kēia mumū, e ʻae ana iā ʻoe e neʻe me ka ʻoluʻolu a komo i nā hana āu e leʻaleʻa ai.

Pehea e hana ai ʻo Adalimumab-fkjp?

Pale ʻo Adalimumab-fkjp i kahi protein i kapa ʻia ʻo tumor necrosis factor (TNF) e hoʻoulu ai i ka mumū i loko o kou kino. Ke loaʻa iā ʻoe kahi maʻi autoimmune, hana kou ʻōnaehana pale i ka nui o ka TNF, e hana ana i ka pehu ʻeha a me ka pōʻino o ka ʻiʻo.

Hana kēia lāʻau lapaʻau e like me ka mea pale i manaʻo ʻia, e pale ana iā TNF mai ka hoʻopaʻa ʻana i nā cell a me ka hana ʻana i ka mumū. Manaʻo ʻia he lāʻau lapaʻau ikaika no ka mea e pili pono ana i ka pane o kāu ʻōnaehana pale. ʻOiai e hana ana kēia i mea maikaʻi loa no ka mālama ʻana i nā maʻi autoimmune, ʻo ia hoʻi e nānā pono kāu kauka iā ʻoe i ka wā o ka mālama ʻana.

ʻIke ʻia nā hopena i loko o 2 a 12 mau pule o ka hoʻomaka ʻana i ka mālama ʻana. Manaʻo kekahi poʻe i ka maikaʻi ma mua, a ʻo nā mea ʻē aʻe paha e pono i nā pule 12 piha e ʻike i nā pōmaikaʻi nui.

Pehea e lawe ai au i ka Adalimumab-fkjp?

E loaʻa iā ʻoe ka adalimumab-fkjp ma ke ʻano he injection ma lalo o kou ʻili, maʻamau i kou ʻūhā a i ʻole ka ʻōpū. E aʻo kāu mea mālama ola iā ʻoe pehea e hoʻokomo ai iā ʻoe iho ma ka home, a i ʻole e loaʻa paha iā ʻoe ma kahi keʻena lapaʻau a i ʻole ke keʻena kauka.

ʻO ka papa hana maʻamau he hoʻokahi injection i kēlā me kēia pule ʻē aʻe, akā hiki i kāu kauka ke hoʻoponopono i kēia ma muli o kou maʻi a me ka pane. He mea nui e hoʻololi i nā wahi injection e pale ai i ka huhū o ka ʻili. Hiki iā ʻoe ke lawe i kēia lāʻau lapaʻau me ka ʻole o ka meaʻai, no ka mea, ʻaʻole ia e pili i ka absorption.

E mālama i kāu lāʻau lapaʻau i loko o ka pahu hau a e ʻae iā ia e hiki i ka mahana o ka lumi ma mua o ka hoʻokomo ʻana. Mai lulu i ka vial a i ʻole ka peni i hoʻopiha mua ʻia, no ka mea, hiki i kēia ke hōʻino i ka lāʻau lapaʻau. E hāʻawi kāu hui mālama ola i nā ʻōlelo kikoʻī e pili ana i ka ʻenehana injection kūpono a me ka mālama ʻana.

Pehea ka lōʻihi e lawe ai au i ka Adalimumab-fkjp?

ʻO ka hapa nui o nā kānaka e lawe i ka adalimumab-fkjp no nā mahina a i ʻole nā makahiki, ma muli o ko lākou maʻi a me ka maikaʻi o kā lākou pane ʻana i ka lāʻau. He maʻi maʻamau nā maʻi autoimmune, ʻo ia hoʻi e pono lākou i ka mālama mau ʻana ma mua o ka lāʻau lapaʻau pōkole.

E loiloi mau kāu kauka i ka maikaʻi o ka hana ʻana o ka lāʻau a inā paha e ʻike ana ʻoe i nā hopena ʻaoʻao e hopohopo nei. Hiki i kekahi poʻe ke hōʻemi i kā lākou alapine dosing i ka manawa, aʻo nā mea ʻē aʻe e mālama i ka papa like no nā makahiki. ʻO ka pahuhopu ka loaʻa ʻana o ke kaulike kūpono ma waena o ka mālama ʻana i kāu mau hōʻailona a me ka hōʻemi ʻana i nā pilikia hiki.

Mai hooki i ka lawe ʻana i kēia lāʻau lapaʻau me ka ʻole e kamaʻilio mua me kāu kauka. ʻO ka hooki ʻana i ka pōkole hiki ke hoʻi koke mai kāu mau hōʻailona a hiki ke ʻino.

He aha nā hopena ʻaoʻao o Adalimumab-fkjp?

E like me nā lāʻau lapaʻau a pau, hiki i ka adalimumab-fkjp ke hana i nā hopena ʻaoʻao, ʻoiai ʻaʻole ʻike nā kānaka a pau iā lākou. Hiki ke mālama ʻia ka hapa nui o nā hopena ʻaoʻao, a e kōkua kāu hui mālama ola iā ʻoe e hoʻokele i nā hopohopo e kū mai.

ʻO nā hopena ʻaoʻao maʻamau āu e ʻike ai, ʻo ia:

• Nā hopena ma ke kahua injection e like me ka ʻulaʻula, ka pehu, a i ʻole ka ʻūlū
• Nā maʻi hanu luna a i ʻole nā ​​hōʻailona e like me ke anu
• Poʻo
• Luhi
• Nausea
• ʻEha ʻiʻo
• Pāpaʻi ʻili

He maʻalahi kēia mau hopena a pinepine e hoʻomaikaʻi i ka wā e hoʻoponopono ai kou kino i ka lāʻau. ʻO nā hopena ma ke kahua injection ka mea maʻamau a maʻa mau e hoʻoponopono i loko o kekahi mau lā.

Pono nā hopena ʻaoʻao koʻikoʻi i ka lāʻau lapaʻau koke, ʻoiai ʻaʻole lākou i maʻamau:

• Nā hōʻailona o ka maʻi koʻikoʻi e like me ke kuni, nā anu, a i ʻole ka ʻū mau
• ʻO ka ʻeha ʻole a i ʻole ke kahe ʻana
• ʻEha ʻōpū nui
• Melemele o ka ʻili a i ʻole nā ​​maka
• Nā hopena ʻili koʻikoʻi a i ʻole nā ​​ulu hou
• ʻO ka ʻeha a i ʻole ka ʻūlū ʻana i nā lima a i ʻole nā ​​wāwae

E nānā mau kāu kauka iā ʻoe no kēia mau hopena koʻikoʻi a hoʻoponopono i kāu hoʻolālā lapaʻau inā pono.

ʻO wai ka mea pono ʻole e lawe iā Adalimumab-fkjp?

ʻAʻole pono kekahi poʻe e lawe iā adalimumab-fkjp ma muli o ka piʻi ʻana o nā pilikia a i ʻole nā pilikia hiki ke loaʻa. E nānā pono kāu kauka i kāu mōʻaukala olakino ma mua o ke kau ʻana i kēia lāʻau.

Pono ʻoe e pale i kēia lāʻau inā loaʻa iā ʻoe:

• Nā maʻi koʻikoʻi ikaika
• Tuberculosis ikaika
• ʻAʻole maikaʻi ka puʻuwai
• Nā maʻi maʻi i ʻike ʻia i ka adalimumab a i ʻole kāna mau meaʻai
• Nā ʻano maʻi maʻi
• Nā lāʻau lapaʻau ola i hoʻonohonoho ʻia

E mālama pū kāu kauka inā he moʻolelo kou o nā maʻi e hana hou ana, hepatitis B, multiple sclerosis, a i ʻole ka huakaʻi hou ʻana i nā wahi i maʻamau ai kekahi mau maʻi fungal. ʻAʻole pono kēia mau kūlana e pale iā ʻoe mai ka lawe ʻana i ka lāʻau, akā pono lākou i ka nānā pono ʻana.

Pono nā wahine hāpai a me nā wahine e hānai ana i ka umauma i ka noʻonoʻo kūikawā, no ka mea, hiki i ka lāʻau lapaʻau ke hele i ka placenta a pili i nā pēpē e hānai ana.

Nā inoa inoa Adalimumab-fkjp

Loaʻa ʻo Adalimumab-fkjp ma lalo o ka inoa inoa ʻo Hulio ma ʻAmelika Hui Pū ʻIa. Ua hoʻomohala ʻia kēia biosimilar e hāʻawi i nā pono lapaʻau like me ka lāʻau adalimumab mua ma ke kumu kūʻai haʻahaʻa.

Hiki nō hoʻi i kāu hale kūʻai lāʻau lapaʻau ke kuhikuhi iā ia ma kona inoa maʻamau, adalimumab-fkjp, ʻoiai ke kūkākūkā ʻana i ka ʻinikua a i ʻole nā koho lāʻau. E pili ana nā inoa ʻelua i ka lāʻau lapaʻau like, no laila, mai hopohopo inā ʻoe e ʻike i nā ʻōlelo like ʻole ma kāu ʻōmole kuhikuhi a i ʻole nā palapala ʻinikua.

Nā koho ʻē aʻe Adalimumab-fkjp

Nui nā koho ʻē aʻe inā ʻaʻole kūpono ʻo adalimumab-fkjp iā ʻoe a i ʻole ʻaʻole hāʻawi i ka hōʻoluʻolu hōʻailona kūpono. Hiki i kāu kauka ke noʻonoʻo i nā mea pale TNF ʻē aʻe a i ʻole nā papa lāʻau lapaʻau like ʻole.

ʻO nā koho pale TNF ʻē aʻe e pili ana:

• Etanercept (Enbrel)
• Infliximab (Remicade)
• Certolizumab (Cimzia)
• Golimumab (Simponi)

ʻO nā koho ʻē aʻe ʻaʻole TNF biologic e komo pū ana i nā lāʻau e mālama ana i nā ʻāpana like ʻole o ka ʻōnaehana pale, e like me rituximab, abatacept, a i ʻole tocilizumab. Hiki i kāu kauka ke noʻonoʻo i nā lāʻau antirheumatic e hoʻololi ana i ka maʻi (DMARDs) e like me methotrexate a i ʻole sulfasalazine.

Aia ke koho maikaʻi loa ma muli o kou kūlana kikoʻī, nā pane lapaʻau mua, a me nā mea olakino pilikino.

Ua ʻoi aku ka maikaʻi o Adalimumab-fkjp ma mua o Humira?

Hana ʻo Adalimumab-fkjp a me Humira ma ke ʻano like a hāʻawi i nā pōmaikaʻi like no ka mālama ʻana i nā maʻi autoimmune. ʻO Humira ka inoa inoa mua o ka lāʻau, ʻoiai ʻo adalimumab-fkjp he mana biosimilar i hele i nā hoʻokolohua nui e hōʻoia i ka hana maikaʻi.

ʻO ka pōmaikaʻi nui o adalimumab-fkjp ʻo ka mālama kālā. ʻO ka maʻamau, ʻoi aku ka liʻiliʻi o nā biosimilars ma mua o 15-30% ma mua o ka lāʻau mua, e hoʻolilo ana i ka mālama ʻana i mea kūpono no ʻoe a me kāu ʻoihana ʻinikua. Hiki i kēia ke hōʻemi nui i kāu mau lilo mai ka ʻeke i ka manawa.

Hōʻike nā haʻawina e mālama ka poʻe e hoʻololi ana mai Humira i adalimumab-fkjp i ka pae like o ka mālama ʻana i nā hōʻailona a ʻike i nā ʻano hopena ʻaoʻao like. Hiki i kāu kauka ke kōkua iā ʻoe e hoʻoholo inā he mea kūpono ka hoʻololi ʻana ma muli o kāu ʻinikua a me ka pane ʻana i ka lāʻau.

Nā Nīnau i Nīnau Pinepine e pili ana iā Adalimumab-fkjp

He palekana anei ʻo Adalimumab-fkjp no ka poʻe me ka maʻi diabetes?

ʻAe, palekana ʻo adalimumab-fkjp no ka poʻe me ka maʻi diabetes, akā pono ka nānā pono ʻana. ʻAʻole pili pololei ka lāʻau i nā pae kōpaʻa koko, akā hiki iā ia ke hoʻonui i kou pilikia o nā maʻi, hiki ke ʻoi aku ka koʻikoʻi i ka poʻe me ka maʻi diabetes.

E makemake ana kāu kauka e hōʻoia i ka maikaʻi o kāu maʻi diabetes ma mua o ka hoʻomaka ʻana i ka lapaʻau. E nānā pū lākou iā ʻoe no nā hōʻailona o ka maʻi a hiki ke hoʻoponopono i kāu mau lāʻau lapaʻau diabetes inā pono. ʻO ka mālama maikaʻi ʻana i ke kō koko e kōkua maoli nō ia i ka hōʻemi ʻana i kou pilikia o ka maʻi i ka wā e lawe ana i kēia lāʻau.

He aha kaʻu e hana ai inā ua hoʻohana hewa au i ka nui o Adalimumab-fkjp?

Inā ua hoʻokomo hewa ʻoe i ka nui o adalimumab-fkjp ma mua o ka mea i kauoha ʻia, e kelepona koke i kāu kauka a i ʻole ka mea mālama ola. ʻOiai he kakaikahi nā mea i ʻoi aku ka nui o kēia lāʻau, hiki i ka lawe ʻana i ka nui ke hoʻonui i kou pilikia o nā hopena ʻaoʻao koʻikoʻi, ʻo ka maʻi.

Mai hoʻāʻo e uku ma ka haʻalele ʻana i kāu mahele i hoʻonohonoho ʻia e hiki mai ana. Akā, e hahai i ke alakaʻi a kāu kauka e pili ana i ka hana ʻana me kāu papa hana maʻamau. Hiki iā lākou ke makemake e nānā iā ʻoe no nā hopena ʻaoʻao a i ʻole e hoʻoponopono i kāu hoʻolālā lapaʻau no kekahi manawa.

He aha kaʻu e hana ai inā ua hala au i kahi mahele o Adalimumab-fkjp?

Inā ua hala ʻoe i kahi mahele, e lawe ia i ka wā e hoʻomanaʻo ai ʻoe, ke ʻole ua kokoke ka manawa no kāu injection i hoʻonohonoho ʻia e hiki mai ana. I kēlā hihia, e haʻalele i ka mahele i hala a hoʻi i kāu papa hana maʻamau. Mai lawe i ʻelua mahele i ka manawa hoʻokahi e uku ai i kahi injection i hala.

E kelepona i kāu mea mālama ola inā ʻaʻole ʻoe maopopo e pili ana i ka manawa a i ʻole inā ua hala ʻoe i nā mahele he nui. Hiki iā lākou ke kōkua iā ʻoe e hoʻi i ke ala a hōʻoia i ka maikaʻi o kāu lapaʻau. ʻO ka hala ʻana i nā mahele i kekahi manawa ʻaʻole ia e hoʻopilikia koke, akā he mea nui ka kūlike no nā hopena maikaʻi loa.

I ka manawa hea e hiki ai iaʻu ke hooki i ka lawe ʻana iā Adalimumab-fkjp?

Pono ʻoe e hooki i ka lawe ʻana iā adalimumab-fkjp ma lalo o ke alakaʻi a kāu kauka. ʻO ka hapa nui o nā maʻi autoimmune he maʻi maʻi, ʻo ia hoʻi e pono lākou i ka lapaʻau mau e pale ai i nā hōʻailona mai ka hoʻi ʻana mai. ʻO ka hooki ʻana i ka lāʻau lapaʻau e hoʻi mālie nā hōʻailona i loko o kekahi mau pule a i ʻole mau mahina.

Hiki i kāu kauka ke noʻonoʻo e hōʻemi i kāu lāʻau a i ʻole e hooki i ka lapaʻau inā ua noho ʻoe i ke kala ʻana no ka manawa lōʻihi, inā e loaʻa ana nā hopena ʻaoʻao koʻikoʻi, a i ʻole inā e hoʻolālā ana ʻoe i ke ʻoki. E hana lākou i kahi hoʻolālā e nānā pono iā ʻoe i ka wā o nā loli lapaʻau e hōʻoia i ka paʻa ʻana o kou kūlana.

Hiki iaʻu ke loaʻa nā lāʻau lapaʻau i ka wā e lawe ana iā Adalimumab-fkjp?

Hiki iā ʻoe ke loaʻa ka hapa nui o nā lāʻau lapaʻau i ka wā e lawe ana iā adalimumab-fkjp, akā pono ʻoe e pale i nā lāʻau lapaʻau ola. Aia i loko o nā lāʻau lapaʻau ola nā maʻi maʻi nāwaliwali akā ola e hiki ke hoʻoulu i nā maʻi i ka poʻe me nā ʻōnaehana pale i kāohi ʻia.

ʻO nā lāʻau lapaʻau palekana e pili ana i nā pana flu, nā lāʻau lapaʻau pneumonia, a me nā lāʻau lapaʻau COVID-19. Hiki i kāu kauka ke ʻōlelo aku i ka manawa o nā lāʻau lapaʻau ma waena o nā lāʻau a i ʻole e hoʻomaha i ka lapaʻau no kekahi mau lāʻau lapaʻau. E hōʻike mau i nā mea mālama ola e lawe ana ʻoe i kēia lāʻau ma mua o ka loaʻa ʻana o kekahi lāʻau lapaʻau.